Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/16/2003WO2003085375A2 Hcv antiviral and cytotoxicity drug screening assay
10/16/2003WO2003085372A2 Biosensor membranes composed of polymers containing heterocyclic nitrogens
10/16/2003WO2003085138A1 Methods of virus production
10/16/2003WO2003085135A1 New method
10/16/2003WO2003085134A2 Methods of diagnosing and treating colorectal cancer
10/16/2003WO2003085133A2 Novel fissr-pcr primers and method of genotyping diverse genomes of plant and animal systems including rice varieties
10/16/2003WO2003085132A2 Method for analysis of methylated nucleic acids
10/16/2003WO2003085131A2 Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases
10/16/2003WO2003085130A1 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
10/16/2003WO2003085129A1 Detection of mycobacteria in clinical material
10/16/2003WO2003085128A1 Method for detecting a mutation in a gene which predisposes for hereditary colorectal tumours
10/16/2003WO2003085126A1 Method of estimating elimination of microorganisms and apparatus for estimating elimination of microorganisms
10/16/2003WO2003085125A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085115A2 Identification and validation of novel targets for agrochemicals
10/16/2003WO2003085113A1 Enhancer sequence of the 5-aminolevulinic acid synthase gene
10/16/2003WO2003085112A1 Enhancer sequence of the 5-aminolevulinic synthase gene
10/16/2003WO2003085106A1 Preventives and/or remedies for cancer
10/16/2003WO2003085098A2 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti
10/16/2003WO2003085096A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085095A2 Novel expressed genes
10/16/2003WO2003085090A2 A human ribonucleotide reductase m2 subunit
10/16/2003WO2003085086A2 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003WO2003085084A2 Hepatitis c virus sub-genomic replicons
10/16/2003WO2003085083A2 Liver necrosis predictive genes
10/16/2003WO2003084989A2 La1 - the genome of a lactobacillus strain
10/16/2003WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain
10/16/2003WO2003084480A2 HAUSP-p53 INTERACTION AND USES THEREOF
10/16/2003WO2003084479A2 Large scale methods of producing adenovirus and adenovirus seed stocks
10/16/2003WO2003084471A2 Compositions selective for adenosine diphosphate and methods of using same
10/16/2003WO2003084384A2 Diagnosis of flavivirus infection
10/16/2003WO2003084333A1 Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
10/16/2003WO2003073104A3 Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases
10/16/2003WO2003070976A3 Methods for determining the influence of protein binding on antiretroviral activity
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003066876A9 An apparatus and methods for using biological material to discriminate an agent
10/16/2003WO2003065875A3 Method and test strips for the measurement of fat loss during weight loss programs
10/16/2003WO2003062826A3 Materials and methods for examining and treating nasopharyngeal carcinoma
10/16/2003WO2003062786A3 Biosensor for small molecule analytes
10/16/2003WO2003057909A3 Method for detecting cytosine-methylation patterns by exponential ligation of hybridised probe oligo-nucleotides (mla)
10/16/2003WO2003057258A3 Quantitative ranking of transient ligand binding to target biomolecules
10/16/2003WO2003057009A3 Genetic changes in atypical nodular proliferations in congenital melanocytic nevi
10/16/2003WO2003056912A3 Inducible transposition in transgenic organism using transposon vector
10/16/2003WO2003054549A3 Method of mass spectrometry
10/16/2003WO2003051905A3 Taojiks as modifiers of the beta-catenin pathway and methods of use
10/16/2003WO2003049677A3 Mesoporous permeation layers for use on active electronic matrix devices
10/16/2003WO2003048902A3 Library screening
10/16/2003WO2003048387A3 Labelled nucleotides
10/16/2003WO2003046219A3 Amperometric affinity assay and electrically stimulated complexes of nucleic acids
10/16/2003WO2003046148A3 Polypeptide quantitation
10/16/2003WO2003044176A9 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
10/16/2003WO2003042661A8 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
10/16/2003WO2003042369A3 Cellular kinase targets and inhibitors, and methods for their use
10/16/2003WO2003040406A3 Diagnosis of clinical infection of a wound
10/16/2003WO2003040177A3 Nucleic acid derived from an alpv virus, compositions containing said nucleic acid and uses thereof
10/16/2003WO2003038000A8 Marking solution for counterfeit-resistant identification of a valuable object, marking produced by the marking solution and method for marking a valuable object
10/16/2003WO2003035904A3 Methods and compositions to evaluate antibody treatment response
10/16/2003WO2003034069A3 Tcmp 03 protein for use in cancer therapy
10/16/2003WO2003033660A3 9136, a human aldehyde dehydrogenase family member and uses therefor
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003027656A3 Electrochemical control of the redox environment for the analysis of a sample
10/16/2003WO2003027309A3 Diagnostic probe detection system
10/16/2003WO2003025540A3 Differential tagging of polymers for high resolution linear analysis
10/16/2003WO2003025224A3 Differential gene expression in schizophrenia
10/16/2003WO2003025127A3 Chromogenic in situ hybridization methods, kits, and compositions
10/16/2003WO2003023062A3 Method of diagnosis for c.trachomatis infection using dna amplification assay on liquid cytology samples
10/16/2003WO2003023055A3 Method for detecting mutations, insertions, deletions and polymorphisms on dna and the use thereof
10/16/2003WO2003022999A3 Rapid detection of replicating cells
10/16/2003WO2003020975A3 OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA
10/16/2003WO2003016559A3 Method for treating diabetes based on the modulation of nh4alpha gene expression
10/16/2003WO2003014733A3 Methods and markers for identifying activated synapses
10/16/2003WO2003014391A3 Method for the detection of a polymorphism in cpb2
10/16/2003WO2003014375A3 Nucleic acid sensor molecules and methods of using same
10/16/2003WO2003014077A3 Crystal forms and mutants of rank ligand
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
10/16/2003WO2003012042A3 Ratio-based oligonucleotide probe selection
10/16/2003WO2003012034A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003WO2003009806A3 Methods for evaluating pathologic conditions using extracellular rna
10/16/2003WO2003008637A3 Use of genotyping in the individualization of therapy
10/16/2003WO2003007685A3 Detecting and treating reproductive tract disorders
10/16/2003WO2003005036A3 Epf receptor assays, compounds and therapeutic compositions
10/16/2003WO2003004704A3 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
10/16/2003WO2003004702A3 Method for determining chromatin structure
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2003002716A3 Polymer stabilized proteinases
10/16/2003WO2003002709A3 Novel technology for genetic mapping
10/16/2003WO2003000930A3 Nucleotide sequences involved in plant disease resistance
10/16/2003WO2002103049A3 Screens for susceptibility to immunodeficiency and viral disease
10/16/2003WO2002099043A3 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002095069A3 Methods
10/16/2003WO2002093176A3 Methods for identifying compounds for treatment of ibd
10/16/2003WO2002092851A3 Genetic typing
10/16/2003WO2002092838A3 Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis
10/16/2003WO2002088081A3 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
10/16/2003WO2002086158A3 Method to analyse the kit genotype of pigs
10/16/2003WO2002086157A3 Use of semaphorin 3a for diagnosing and treating cancer, especially prostate cancer
10/16/2003WO2002083933A3 Method for determining the substrate specificity of an enzymatic activity and a device therefor
10/16/2003WO2002081744A3 Method for determining nucleotide mismatches
10/16/2003WO2002079488A3 Oligonucleotide microchips to detect protein-nucleic acid interactions
1 ... 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 ... 3003